Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Banco de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
J Neurosci ; 25(1): 164-72, 2005 Jan 05.
Artículo en Inglés | MEDLINE | ID: mdl-15634778

RESUMEN

A "gain-of-function" toxic property of mutant Cu-Zn superoxide dismutase 1 (SOD1) is involved in the pathogenesis of some familial cases of amyotrophic lateral sclerosis (ALS). Expression of a mutant form of the human SOD1 gene in mice causes a degeneration of motor neurons, leading to progressive muscle weakness and hindlimb paralysis. Transgenic mice overexpressing a mutant human SOD1 gene (G93A-SOD1) were used to examine the mitochondrial involvement in familial ALS. We observed a decrease in mitochondrial respiration in brain and spinal cord of the G93A-SOD1 mice. This decrease was significant only at the last step of the respiratory chain (complex IV), and it was not observed in transgenic wild-type SOD1 and nontransgenic mice. Interestingly, this decrease was evident even at a very early age in mice, long before any clinical symptoms arose. The effect seemed to be CNS specific, because no decrease was observed in liver mitochondria. Differences in complex IV respiration between brain mitochondria of G93A-SOD1 and control mice were abolished when reduced cytochrome c was used as an electron donor, pinpointing the defect to cytochrome c. Submitochondrial studies showed that cytochrome c in the brain of G93A-SOD1 mice had a reduced association with the inner mitochondrial membrane (IMM). Brain mitochondrial lipids, including cardiolipin, had increased peroxidation in G93A-SOD1 mice. These results suggest a mechanism by which mutant SOD1 can disrupt the association of cytochrome c with the IMM, thereby priming an apoptotic program.


Asunto(s)
Esclerosis Amiotrófica Lateral/metabolismo , Encéfalo/metabolismo , Citocromos c/metabolismo , Membranas Intracelulares/metabolismo , Mitocondrias/metabolismo , Médula Espinal/metabolismo , Envejecimiento/metabolismo , Esclerosis Amiotrófica Lateral/genética , Esclerosis Amiotrófica Lateral/patología , Esclerosis Amiotrófica Lateral/fisiopatología , Animales , Apoptosis , Ácido Ascórbico/metabolismo , Encéfalo/ultraestructura , Modelos Animales de Enfermedad , Transporte de Electrón/efectos de los fármacos , Transporte de Electrón/genética , Complejo IV de Transporte de Electrones/metabolismo , Femenino , Humanos , Membranas Intracelulares/ultraestructura , Peroxidación de Lípido/genética , Masculino , Ratones , Ratones Transgénicos , Mitocondrias/ultraestructura , Óxido Nítrico Sintasa/metabolismo , Médula Espinal/ultraestructura , Superóxido Dismutasa/genética , Superóxido Dismutasa-1 , Tetrametilfenilendiamina/metabolismo
2.
Neurobiol Dis ; 18(1): 126-33, 2005 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-15649703

RESUMEN

Protein kinase C (PKC) was suggested to play a role in the pathology of amyotrophic lateral sclerosis (ALS) patients. Activation of PKC delta (deltaPKC) modulates mitochondrially induced apoptosis. The goal of the present study was to define whether deltaPKC activation occurs in Wobbler mouse spinal cord (a model of motor neuron disease). The level of deltaPKC in the soluble fraction was significantly decreased in the spinal cord of Wobbler mice, which was associated with a significant increase in deltaPKC cleavage. Since caspase-3 is known to cleave deltaPKC, we determined caspase-3 activation in the Wobbler mice spinal cord, immunohistochemically. The results demonstrated intense immunoreactivity for activated caspase-3 in corticospinal tract motor neurons of Wobbler mice spinal cord. We hypothesize from these results that caspase-3 activation cleaves deltaPKC, which in turn promotes an aberrant signal transduction pathway in the Wobbler spinal cord.


Asunto(s)
Esclerosis Amiotrófica Lateral/enzimología , Caspasas/metabolismo , Enfermedad de la Neurona Motora/enzimología , Neuronas Motoras/enzimología , Proteína Quinasa C/metabolismo , Médula Espinal/enzimología , Esclerosis Amiotrófica Lateral/genética , Esclerosis Amiotrófica Lateral/patología , Animales , Caspasa 3 , Modelos Animales de Enfermedad , Regulación hacia Abajo/fisiología , Activación Enzimática , Femenino , Inmunohistoquímica , Masculino , Ratones , Ratones Mutantes Neurológicos , Mitocondrias/enzimología , Corteza Motora/enzimología , Corteza Motora/patología , Enfermedad de la Neurona Motora/genética , Enfermedad de la Neurona Motora/patología , Neuronas Motoras/patología , Degeneración Nerviosa/enzimología , Degeneración Nerviosa/patología , Proteína Quinasa C/genética , Proteína Quinasa C-delta , Transporte de Proteínas , Células Piramidales/enzimología , Células Piramidales/patología , Tractos Piramidales/enzimología , Tractos Piramidales/patología , Transducción de Señal/fisiología , Médula Espinal/patología
3.
J Neurochem ; 88(4): 821-6, 2004 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-14756802

RESUMEN

To test potentially beneficial drugs to amyotrophic lateral sclerosis (ALS), we created an ALS mouse model with a permeable blood-brain barrier, by crossing the G93A-SOD1 transgenic mouse with a multiple drug resistance type 1a/b (mdr1a/b) gene knockout mouse. To validate the model, we administered cyclosporine A intraperitoneally to the mice. Cyclosporine A accumulated in the brain and spinal cord of this mouse model, whereas it was unable to penetrate the CNS of mdr1a/b wild-type animals. Systemic administration of cyclosporine A extended the life of the double-mutant male mice by approximately 12%. Surprisingly, the effect was more robust in male mice and only marginal in female mice. These results demonstrate the usefulness of this combined mouse model for the testing of potentially therapeutic drugs and support the role of mitochondrial-mediated apoptosis in the pathway to motor neuron death in SOD1-associated ALS.


Asunto(s)
Esclerosis Amiotrófica Lateral/tratamiento farmacológico , Barrera Hematoencefálica/fisiopatología , Ciclosporina/uso terapéutico , Inmunosupresores/uso terapéutico , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/genética , Factores de Edad , Alanina/genética , Esclerosis Amiotrófica Lateral/metabolismo , Animales , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Ciclosporina/farmacocinética , Modelos Animales de Enfermedad , Glicina/genética , Humanos , Inmunosupresores/farmacocinética , Hígado/efectos de los fármacos , Hígado/metabolismo , Ratones , Ratones Noqueados , Ratones Transgénicos , Músculos/efectos de los fármacos , Músculos/metabolismo , Probabilidad , Factores Sexuales , Médula Espinal/efectos de los fármacos , Médula Espinal/metabolismo , Superóxido Dismutasa/genética , Superóxido Dismutasa-1 , Tasa de Supervivencia , Distribución Tisular , Tritio/metabolismo
4.
Ann Neurol ; 53(6): 804-7, 2003 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12783429

RESUMEN

We tested whether a regular exercise regimen was associated with a change in the life span of G93A-SOD1 transgenic mice, a model of familial ALS. Regular treadmill running for 10 weeks led to a significant increase in the life span of G93A-SOD1 mice. The effect was stronger in male mice, whereas there was only a trend between exercised and sedentary female G93A-SOD1 mice. The data suggest that regular exercise has a beneficial effect on the progression of ALS.


Asunto(s)
Esclerosis Amiotrófica Lateral/terapia , Condicionamiento Físico Animal , Esclerosis Amiotrófica Lateral/genética , Animales , Modelos Animales de Enfermedad , Femenino , Masculino , Ratones , Ratones Transgénicos , Factores Sexuales
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA